Urology Doctors in Modesto, CA Accepting Medicare

12 Urology doctors found. Showing 1 - 12

Mr. Brian T Mc Caffrey, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388    Fax: 209-523-0764

Walter J Schimon, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-524-1211

Preetinder K. Brar, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-557-1000

Steven R Wunschel, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1401 Spanos Ct, 111, Modesto, CA 95355 Phone: 209-525-3181    Fax: 209-526-4961

Mr. Phillip H Beck, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388    Fax: 209-523-0764

Anvita Sinha, M.D. Urology Medicare: Medicare Enrolled Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-521-6097

Curtis Richard Dewar, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388    Fax: 209-523-0764

Victor M Arroyo, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-524-1211

Uzay Yasar, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1541 Florida Ave, Suite 100, Modesto, CA 95350 Phone: 209-577-3388    Fax: 209-523-0764

Mr. Robert B Eisenberg, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1541 Florida Ave, #100, Modesto, CA 95350 Phone: 209-577-3388    Fax: 209-338-0024

Dr. Lori Beth Schlunt Rawson, M.D. Urology Medicare: Medicare Enrolled Practice Location: 4601 Dale Rd, Modesto, Modesto, CA 95356 Phone: 209-735-7000

Dr. Alexander H Liu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1541 Florida Ave, Suite 200, Modesto, CA 95350 Phone: 209-577-3388    Fax: 209-523-0764

News Archive

Combined, heart disease and stroke account for over 50% of all deaths among Los Angeles County women

The Los Angeles County Office of Women's Health and the American Heart Association have launched a joint heart-health education and stroke prevention program targeting low-income women. Combined, heart disease and stroke account for over 50% of all deaths among Los Angeles County women.

Combination of tosedostat and LDAC results in overall response rate of 54% in elderly patients with AML

CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).

Ibrutinib monotherapy shows efficacy in patients with MCL or DLBCL

Pharmacyclics, Inc. today announced the results of two separate Phase 2 studies suggesting that ibrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, showed efficacy when used as a monotherapy in patients with relapsed/refractory mantle cell lymphoma or diffuse large B-cell lymphoma.

PediaVision device to detect eye disorders in autistic children

PediaVision, a company dedicated to solving the critical problem of undiagnosed vision problems affecting thousands of children, today announced a breakthrough in the use of the PediaVision Assessment Solution for autistic children.

Enzo Biochem announces supply and distribution agreement between Enzo Life Sciences and Cancer Genetics

Enzo Biochem, Inc., a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today a supply and distribution agreement between Enzo Life Sciences and privately-owned Cancer Genetics Inc., a leading producer of nucleic acid products used in genomic research.

Read more Medical News

› Verified 8 days ago